Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel

Why are drug prices so high? Investigating th...

Up next

How to rewire your brain — and find your flow | Heather Berlin

When life gets uncertain, do you grip a little tighter? Neuroscientist Heather Berlin explores a surprising paradox: the harder you try to control everything, the more likely you are to get in your own way. Drawing on brain research and her own struggles with uncertainty, she sha ...  Show more

Sunday Pick: The science on improving your brain health with Dr. Ayesha and Dean Sherzai

When does normal aging end and something more concerning begins? In this episode Shoshana invites neurologist Drs. Ayesha and Dean Sherzai to discuss their studies on Alzheimer’s and Dementia. They debunk myths around Alzheimer, discuss what a brain-healthy way of eating looks li ...  Show more

Recommended Episodes

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Health

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Business

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Is there a healthy future for Big Pharma?
Pharmaceutical Industry: Past, Present and Future

Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry ...  Show more